Grantham, Mayo, Van Otterloo & Co (GMO)
USNA icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Usana Health Sciences USNA Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,900
Closed -$1.61M – 942
2020
Q4 		$1.61M Sell
20,900
-41,800
-67% -$3.23M 0.01% 478
2020
Q3 		$4.62M Buy
62,700
+49,900
+390% +$4M 0.03% 248
2020
Q2 		$940K Buy
+12,800
New +$1M 0.01% 538

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s USNA Position: Q1 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Usana Health Sciences (USNA) in Q1 2021, closing a stake of 20,900 shares — an estimated $1.61M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in USNA in Q2 2020 and held it in 3 quarters. The position peaked at $4.62M in Q3 2020. 198 funds tracked by Wall St. Rank hold USNA as of Q1 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Usana Health Sciences position as of Q1 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 20,900 Usana Health Sciences shares in Q1 2021, an estimated $1.61M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Usana Health Sciences in Q2 2020 and held it in 3 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Usana Health Sciences position peaked at $4.62M in Q3 2020.
  • 198 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2021, filed 13 May 2021.